A retrospective, real word study of metastatic castration-resistant prostate cancer (mCRPC) patients who treated with cabazitaxel
Latest Information Update: 09 Oct 2020
At a glance
- Drugs Cabazitaxel (Primary) ; Abiraterone; Docetaxel; Enzalutamide
- Indications Prostate cancer
- Focus Therapeutic Use
- 09 Oct 2020 New trial record
- 21 Sep 2020 Results presented at the 45th European Society for Medical Oncology Congress